Tenax Therapeutics (TENX) Preferred Dividend Payments (2013 - 2014)
Tenax Therapeutics recorded quarterly Preferred Dividend Payments of $11.5 million in Q2 2014, up 1153.59% quarter-over-quarter from -$1.1 million in Q1 2014, and up 1105.08% year-over-year from $958071.0 in Q2 2013.
Tenax Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $11.5 million for Q2 2014.
- In Q2 2014, Preferred Dividend Payments rose 1105.08% year-over-year to $11.5 million; the TTM figure through Jan 2015 stood at $11.5 million (up 341.33% YoY), while the FY2018 annual figure was $7.3 million, changed N/A from the prior year.
- Preferred Dividend Payments came in at $11.5 million for Q2 2014 at Tenax Therapeutics, up from -$1.1 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $11.5 million in Q2 2014 to a low of -$2.6 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2014 | 11.55 Mn |
| Jan 31, 2014 | -1.10 Mn |
| Oct 31, 2013 | -2.55 Mn |
| Jul 31, 2013 | -2.09 Mn |
| Apr 30, 2013 | 958,071.00 |